#1 Clinical Trials Search in Europe

Betahistine Dihydrochloride

Betahistine Dihydrochloride, a medication with diverse applications, has been the subject of several clinical trials investigating its potential benefits in various medical conditions. These trials have explored its use in treating atypical depression, managing obesity, improving cerebral blood flow, and even its pharmacokinetic profile when combined with other medications. This article delves into the recent clinical studies of Betahistine Dihydrochloride, shedding light on its potential therapeutic uses and effects on the human body.

Table of Contents

What is Betahistine Dihydrochloride?

Betahistine Dihydrochloride, also known by brand names such as SERC, Agiserc®, and Vasomotal, is a medication that has been the subject of several clinical trials for various medical conditions[1][3][4]. It’s a drug that affects the body’s histamine system, which is involved in many physiological processes including balance, blood flow, and appetite regulation.

Conditions Treated with Betahistine

Betahistine is primarily used and studied for the following conditions:

  • Ménière’s Disease: This is a disorder of the inner ear that can cause vertigo (a spinning sensation), hearing loss, and tinnitus (ringing in the ears). Betahistine is commonly prescribed for this condition[4].
  • Major Depression with Atypical Features: Some research is exploring the potential of betahistine in treating this specific type of depression. Atypical depression is characterized by mood improvements in response to positive events, increased appetite, increased sleep, and severe fatigue[1].
  • Obesity: Studies have investigated betahistine’s potential effects on body weight in obese individuals[2].
  • Gait or Balance Disorder Problems: Research has looked into betahistine’s effects on cerebral blood flow and its potential to improve gait and balance issues[3].

How Betahistine Works

Betahistine is believed to work in several ways:

  1. Improving Blood Flow: One of the primary mechanisms of betahistine is its ability to enhance cerebral blood flow (CBF). This means it can increase the amount of blood flowing to the brain, which may help with various neurological symptoms[3].
  2. Affecting Histamine Receptors: Betahistine interacts with histamine receptors in the body. This interaction is thought to help with balance disorders and other symptoms associated with conditions like Ménière’s disease.
  3. Potential Metabolic Effects: Some research suggests that betahistine might influence body weight, though more studies are needed to confirm this effect[2].

Dosage and Administration

The dosage of betahistine can vary depending on the condition being treated and the specific study protocol. Here are some examples from clinical trials:

  • For depression studies: Doses ranged from 50 mg to 300 mg daily, taken orally[1].
  • For obesity studies: Doses of 48 mg/day or 96 mg/day were used, taken as 24 mg or 48 mg twice daily[2].
  • For cerebral blood flow studies: A dose of 24 mg twice daily was used[3].

It’s important to note that these dosages are from clinical trials and may not reflect the typical dosages prescribed by doctors. Always follow your healthcare provider’s instructions regarding medication use.

Ongoing Research and Potential Uses

Betahistine is the subject of ongoing research to explore its potential benefits in various conditions:

  • Depression Treatment: Studies are investigating its use in major depression with atypical features[1].
  • Weight Management: Research is exploring its potential effects on body weight in obese individuals[2].
  • Cerebral Blood Flow: Studies are looking at how betahistine affects blood flow in the brain and whether this can improve gait and cognitive function[3].
  • Pharmacokinetics: Research is being conducted to understand how betahistine is processed in the body, especially when combined with other medications like selegiline[4].

Side Effects and Safety

While betahistine is generally considered safe, it can cause side effects. Clinical trials often monitor for adverse effects to ensure patient safety. Common side effects may include:

  • Headache
  • Nausea
  • Indigestion
  • Itching

In clinical trials, researchers closely monitor participants for any adverse effects. This includes regular check-ups, blood tests, and other safety assessments[4]. It’s important to report any unusual symptoms to your healthcare provider when taking any medication.

Remember, betahistine should only be taken under the supervision of a healthcare professional. They will consider your individual health status and other medications you may be taking to determine if betahistine is appropriate for you.

Study Focus Condition Dosage Duration Key Outcome Measures
Depression Treatment Atypical Depression 50-300 mg daily 3 weeks Maximum tolerable dose
Obesity Management Obesity 48 mg/day or 96 mg/day 12 weeks Change in body weight
Cerebral Blood Flow Gait or Balance Disorders 24 mg twice daily 6 weeks Changes in cerebral blood flow
Pharmacokinetics Ménière’s Disease 24 mg, 48 mg, 96 mg Variable Betahistine serum concentration

FAQ

  • What conditions are being studied with Betahistine Dihydrochloride in clinical trials? Clinical trials are exploring Betahistine Dihydrochloride for various conditions, including atypical depression, obesity, gait or balance disorder problems, and Ménière's Disease. It's also being studied for its effects on cerebral blood flow.
  • How is Betahistine Dihydrochloride being tested for obesity treatment? In a study for obesity treatment, Betahistine Dihydrochloride is being tested in different doses (48 mg/day and 96 mg/day) against a placebo. The study focuses on obese female subjects and measures changes in body weight over a 12-week period.
  • What is the purpose of studying Betahistine's effect on cerebral blood flow? The study on cerebral blood flow aims to explore if Betahistine can enhance blood flow in the brain, particularly in patients with MRI evidence of cerebrovascular compromise. This could potentially benefit those with gait or balance disorder problems.
  • How is Betahistine Dihydrochloride being investigated for depression treatment? A pilot study is investigating Betahistine Dihydrochloride for treating major depression with atypical features. The study aims to determine a well-tolerated and potentially effective dose, starting from 50 mg and potentially increasing to 300 mg daily.
  • What is being studied about Betahistine's interaction with other medications? A pharmacokinetic study is investigating how Betahistine interacts with Selegiline. The study aims to determine if the combination of these medications affects Betahistine's concentration in the blood and to assess the safety of this combination.

Ongoing Clinical Trials on Betahistine Dihydrochloride

  • Study on Betahistine Dihydrochloride for Treating Adults with Menière’s Disease

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Betahistine Dihydrochloride: A medication being studied for various conditions including depression, obesity, and balance disorders. It's also known by brand names like SERC, Agiserc, and Vasomotal.
  • Atypical Depression: A type of depression characterized by mood improvements in response to positive events, increased appetite, increased sleep, and severe fatigue.
  • Cerebral Blood Flow (CBF): The blood supply to the brain in a given time. In some studies, Betahistine is being investigated for its potential to enhance CBF.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Ménière's Disease: A disorder of the inner ear that can cause vertigo, tinnitus, hearing loss, and a feeling of fullness in the ear.
  • Placebo: A substance with no active therapeutic effect, used as a control in testing new drugs.
  • Titration: The process of gradually adjusting the dose of a medication to determine the optimal dosage.
  • MRI: Magnetic Resonance Imaging, a medical imaging technique used to form pictures of the anatomy and physiological processes of the body.
  • AUC (Area Under the Curve): A measurement used in pharmacology to describe the total drug exposure over time.
  • Selegiline: A medication used in the treatment of Parkinson's disease, sometimes studied in combination with Betahistine.

References

  1. https://clinicaltrials.gov/study/NCT00585585
  2. https://clinicaltrials.gov/study/NCT00748436
  3. https://clinicaltrials.gov/study/NCT01468285
  4. https://clinicaltrials.gov/study/NCT05938517